posted on 2001-10-10, 00:00authored byRobert M. Garbaccio, Shawn J. Stachel, Daniel K. Baeschlin, Samuel J. Danishefsky
Radicicol (1) exhibits potent anticancer properties in vitro, which are likely to be mediated through
its high affinity (20 nM) for the molecular chaperone Hsp90. Recently, we reported the results of a synthetic
program targeting radicicol (1) and monocillin I (2), highlighted by the application of ring-closing metathesis
to macrolide formation. These efforts resulted in a highly convergent synthesis of radicicol dimethyl ether but
failed in the removal of the two aryl methyl ethers. Simple exchange of these methyl ethers with more labile
functionalities disabled a key esterification in the initial route. Through extended experimentation, a successful
route to both natural products was secured, along with some intriguing results that emphasize the implications
of this design on a broad range of fused benzoaliphatic targets, including analogues of these natural products.